// App-Quantinova.ai

4281 : Overcoming preanalytical variabilities for peripheral blood mononuclear cells and exosome profiling in the IMMUcan multicentre study

Researchers

Presenter

  • Rami Mustapha

Principal Investigators

  • Valentina Pomella

  • Jose Vicencio

  • Silvia Lopez-Lastra

  • Christelle Bahlawane

  • Wim Ammerlaan

  • Henoch S. Hong

  • Marie Morfouace

  • Caoimhe Vallely-Gilroy

  • Vassili Soumelis

  • Emanuela Romano

  • Sabine Tejpar

  • Tony Ng

  • Fay Betsou

Medical Centers

  • Kings College London, London, United Kingdom

  • KU Leuven, Leuven, Belgium

  • Kings College London, London, United Kingdom

  • Institute Curie, PSL Research University, INSERM, Paris, France

  • Integrated BioBank of Luxembourg, Dudelange, Luxembourg

  • Merck KGaA, Darmstadt, Germany

  • EORTC HQ, Brussels, Belgium

Locations

  • United Kingdom

  • Belgium

  • France

  • Luxembourg

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Natural Killer cells

  • Peripheral blood mononuclear cell

  • Programmed death-ligand 1

  • Epidermal growth factor receptor

  • erb-b2 receptor tyrosine kinase 2

  • Erb-B2 Receptor Tyrosine Kinase 3

Drug/Treatment

  • Tamsulosin Hydrochloride

Outcome

  • N/A

Study Design

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved